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Ehlers-Danlos type IV (EDS-IV) is an inherited condition most notable for its associated vascular complications. Patients
are prone to aneurysm formation, arterial dissection, and spontaneous vessel rupture. Intervention for the vascular
pathology of EDS-IV carries high morbidity and mortality. We describe a case of a 57-year-old man with EDS-IV and an
expanding iliac aneurysmwho underwent successful endovascular repair with a stent-graft. Endovascular aneurysm repair
is feasible and should be considered for patients with EDS-IV. (J Vasc Surg 2007;45:177-9.)Ehlers-Danlos syndrome (EDS) refers to a diverse
group of heritable connective tissue disorders, of which
type IV (EDS-IV) accounts for 4%. EDS-IV results from
an autosomal dominant mutation in the COL3A1 gene
that causes a defect of type III collagen production.
Typical findings of severe joint hypermobility and skin
hyperelasticity associated with other subtypes of EDS are
rare with type IV. The clinical hallmark of EDS-IV is
extraordinary tissue fragility resulting in uterine rupture,
spontaneous intestinal perforation, and a multitude of
vascular maladies (aneurysms, pseudoaneurysms, dissec-
tions, and spontaneous rupture).1 A disease-related
complication affects 25% of these patients by age 20 and
80% by age 40.2
The vascular complications of EDS-IV usually account
for the premature deaths in this population, with a median
survival into the fifth and sixth decades. The EDS-IV
patient often presents emergently secondary to vascular
rupture and without a diagnosis of the underlying genetic
condition. The reported operative mortality (including
emergent cases) ranges from 7% to 41%.2-4 Inability to
control bleeding from vessels with the consistency of “wet
tissue paper” results in the demise of these patients. Even
angiography carries 3% to 17% mortality and 23% to 67%
morbidity2,3 as a result of access site complications and
remote vessel injury.
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favors nonintervention whenever possible, with operation
reserved for emergent or potentially life-threatening condi-
tions. We report a case of a symptomatic and rapidly ex-
panding iliac aneurysm in a 57-year-old man with EDS-IV.
Endovascular aneurysm repair (EVAR) successfully ex-
cluded the aneurysm. To our knowledge, this is the first
report of iliac artery EVAR in a patient with EDS-IV.
CASE REPORT
A 57-year-old man was referred for a right iliac aneurysm
incidentally found on ultrasonography. Three years before, he
experienced the spontaneous rupture of an unknown vessel in
his neck; this was reportedly treated by ligation. Subsequently,
EDS-IV was diagnosed by identification of abnormal type III
procollagen by fibroblast cell culture and gel electrophoresis.
The diagnosis was completed by identification of a point muta-
tion in the COL3A1 gene (arginine for glycine at amino acid
634). Medical history was also pertinent for a spontaneous
hemothorax in 1992 treated by tube thoracostomy. He re-
ported bruising easily with minimal trauma. Family history was
significant for maternal premature death in her twenties from
pregnancy-related complications.
Physical examination revealed a thin man with prominent eyes
but no other dysmorphism, a well-healed transverse neck incision,
a benign abdominal examination, and 2 peripheral pulses. Com-
puted tomography (CT) scan revealed a right iliac aneurysm2.5 cm in
diameter and a celiac aneurysm measuring 1.6 cm (Fig 1). It was
decided to observe the patient closely. Three-month follow-up CT
demonstrated a 0.5-cm interval growth of the iliac aneurysm. The
patient now reported a several-week history of right lower quad-
rant pain, and on examination he had tenderness over a pulsatile
right lower quadrant fullness.
In light of this rapidly expanding and symptomatic aneurysm,
intervention was recommended, and an endovascular approach
was selected. The aneurysm neck measured 10 mm in width and
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embolize the right hypogastric artery, to minimize vessel manipu-
lation. The procedure was conducted with the patient under
general anesthesia with peripheral intravenous lines, and placement
of arterial and central lines was intentionally avoided. An open
right common femoral artery exposure was performed, and an 8F
sheath was placed. Rather than percutaneously accessing the con-
tralateral side, a second lateral stick was made on the right common
femoral artery to provide angiography access. All wire manipula-
tions were performed under direct fluoroscopy. A 12  105-mm
iliac limb of a Zenith (Cook, Bloomington, Ind) stent graft was
deployed and molded with a compliant balloon. A proximal type I
endoleak was treated with a balloon-expandable stent (Omnilink;
Guidant, Santa Clara, Calif) dilated to 12 mm. As anticipated, a
residual type II endoleak emanated from the right hypogastric artery.
Arteriotomy closure was managed with interrupted, pledgeted su-
tures.
After discharge on postoperative day 1, the patient was en-
rolled in our routine follow-up protocol for EVAR. A contrast-
enhanced CT with 2.5- to 3-mm axial slices is performed at 1, 6,
and12months and then yearly thereafter. Endoleak, sac enlargement,
or migration would evoke more frequent imaging. At follow-up
visits, he had no abdominal pain or gluteal claudication, and serial
CT imaging out to 12 months have continued to demonstrate
stable aneurysm size and no endoleak, corresponding with throm-
bosis of the proximal right hypogastric artery (Fig 2). The celiac
aneurysm has not grown but could be treated with a covered stent
Fig 1. Preoperative computed tomography three-dimensional
reconstructions demonstrate a right common iliac aneurysm with a
proximal neck length of 15 mm and a neck diameter of 10 mm.
The celiac aneurysm is also incidentally shown.were it to enlarge significantly.DISCUSSION
Vascular surgery on EDS-IV patients carries significant
risk and should be embarked upon with appropriate trepi-
dation. In a 30-year experience with an EDS-IV cohort of
31 patients from the Mayo Clinic,4 70% of vascular opera-
tions were performed for emergent or urgent indications.
Major bleeding complications occurred with 37% of inter-
ventions, and 10% of patients died as a direct result of
hemorrhage. Other series report even higher operative
mortalities of 19%3 and 41%.2 In the general population,
the presence of an iliac aneurysm portends a high rate of
rupture; therefore, elective repair above a threshold of 3 cm
is advocated. Both open and endovascular repair of iliac
aneurysms can be accomplished with reasonably low mor-
bidity and mortality.5,6 A higher threshold for any vascular
surgery in the EDS-IV population has been advocated.
Nonetheless, the decision regarding when to operate cre-
ates a management dilemma. In cases of large asymptom-
atic or expanding aneurysms, the vascular surgeon is forced
to walk a fine line. Operating assumes an attendant high
morbidity, whereas conservative observation could under-
treat a patient with imminent rupture risk. Individualized
therapy based on surgical judgment and an informed pa-
tient is the best approach in these nebulous circumstances.
Our patient’s iliac aneurysm was successfully treated
endovascularly with a stent-graft. In the Mayo series, no
patient was treated with endovascular techniques other
than coil embolization.4 Notably, their 40% reported inci-
dence of late graft-related complications was predomi-
nantly from graft-anastomotic aneurysms. Potentially,
EVAR could avoid these late pseudoaneurysms. Despite
our success in this one case, we urge caution before pro-
ceeding with EVAR in EDS-IV patients. The risk of remote
vessel dissection and access-site complications may be sub-
stantial, extrapolating from angiography data. The long-
term results from endograft placement in an EDS-IV pa-
tient are unknown.
With more than 400 mutations identified in the
COL3A1 gene resulting in EDS-IV, correlations between
genotype and phenotypic expression have been difficult to
establish.2,7 The underlying type III procollagen abnor-
mality may result in intracellular retention, reduced secre-
tion, altered mobility, or decreased production of this
protein. Although penetrance of EDS-IV is nearly 100%,
the phenotypic expression varies in severity. Accordingly,
some patients with less fragile tissues may more amenable
to intervention. Presentation earlier in life and a strong
family history of events may indicate a more severe expres-
sion of the syndrome. Our patient’s delayed presentation
could represent a lesser expression of EDS-IV and could
have contributed to his good result with intervention.
Several technical aspects of this case deserve special
mention. This focal iliac aneurysm had a rather short prox-
imal neck (15 mm) that likely contributed to the initial type I
endoleak. This endoleak resolved with a balloon-expandable
stent. In the absence of a suitable neck, options would have
included endovascular repair with a traditional bifurcated
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sively oversized because of concern that excessive radial
forces could rupture the vessel. The hypogastric artery was
not embolized to avoid unnecessary wire and catheter
manipulations in this patient. Growing evidence suggests
that hypogastric embolization may not be necessary for
endovascular aortoiliac aneurysm repair. In two small series
(n  11 and n  22),8,9 intentional coverage of the
hypogastric artery resulted in thrombosis and no late en-
doleak in 100% of cases. In fact, hypogastric embolization
not infrequently results in significant gluteal claudica-
tion9,10 and rarely can lead to colon ischemia or perineal
necrosis. Because most type II endoleaks spontaneously
thrombose, the treatment of type II endoleaks can be
reserved for those with persistent endoleak and aneurysm
expansion.11
To our knowledge, this is the first report of iliac artery
EVAR in an EDS-IV patient. A single case of covered stent
treatment for a hepatic artery aneurysm has been reported
in the international literature.12 All vascular interventions
in patients with EDS-IV carry a high risk of morbidity and
mortality. Elective vascular procedures should be avoided
when possible, and when necessary, they should be metic-
ulously planned and judiciously enacted. EVAR for EDS-IV
patients is feasible and should be considered as an alternative
to open surgery in these challenging cases.
REFERENCES
1. Barabas AP. Vascular complications in the Ehlers-Danlos syndrome,
with special reference to the “arterial type” or Sack’s syndrome. J Car-
diovasc Surg 1972;13:160-7.
2. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic
features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl
Fig 2. Follow-up axial computed tomography images at
stent graft is seen within the thrombosed aneurysm sac w
proximal right hypogastric artery.J Med 2000;342:673-80.3. Cikrit DF, Miles JH, Silver D. Spontaneous arterial perforation: the
Ehlers-Danlos specter. J Vasc Surg 1987;5:248-55.
4. Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel
AA, et al. The spectrum, management and clinical outcome of Ehlers-
Danlos type IV: a 30-year experience. J Vasc Surg 2005;42:98-106.
5. Krupski WC, Selzman CH, Floridia R, Strecker PK, Nehler MR,White-
hill TA. Contemporary management of isolated iliac aneurysms. J Vasc
Surg 1998;28:1-13.
6. Parsons RE, Marin FL, Veith FJ, Parsons RB, Hollier LH. Midterm
results of endovascular stented grafts for the treatment of isolated iliac
artery aneurysms. J Vasc Surg 1999;30:915-21.
7. Schwarze U, Schievink WI, Petty E, Jaff MR, Babovic-Vuksanovic D,
Cherry KJ, et al. Haploinsufficiency for one COL3A1 allele of type III
procollagen results in a phenotype similar to the vascular form of
Ehlers-Danlos syndrome type IV. Am J Hum Genet 2001;69:989-
1001.
8. Tefera G, Turnipseed WD, Carr SC, Pulfer KA, Hoch JR, Acher CW.
Is coil embolization of hypogastric artery necessary during endovas-
cular treatment of aortoiliac aneurysms? Ann Vasc Surg 2004;18:
143-6.
9. Wyers MC, Schermerhorn ML, Fillinger MF, Powell RJ, Rzucidlo EM,
Walsh DB, et al. Internal iliac occlusion without coil embolization
during endovascular abdominal aortic aneurysm repair. J Vasc Surg
2002;36:1138-45.
10. Criado FJ, Wilson EP, Velazquez OC, Carpenter JP, Barker C,
Wellons E, et al. Safety of coil embolization of the internal iliac artery
in endovascular grafting of abdominal aortic aneurysms. J Vasc Surg
2000;32:684-8.
11. van Marrewijk C, Buth J, Harris PL, Norgren L, Nevelsteen A, Wyatt
MG. Significance of endoleaks after endovascular repair of abdomi-
nal aortic aneurysms: the EUROSTAR experience. J Vasc Surg
2002;35:461-73.
12. Casana R, Nano G, Dalainas I, Tealdi DG. Endovascular treatment of
hepatic artery aneurysm in a patient with Ehlers-Danlos syndrome, case
report. Int Angiol 2004;23:291-5.
nths demonstrate a stable aneurysm size at 3 cm.A, The
endoleak. B, A more distal slice shows the thrombosed2mo
ith noSubmitted Feb 16, 2006; accepted Aug 26, 2006.
